LRRK2 and Parkinson disease: These studies indicate variable neuropathology in LRRK2 mutation carriers, including typical Lewy bodies, tau pathology, or nigral degeneration without Lewy bodies. Suggests LRRK2 mutations may predict specific PD sequelae.